China Meheco Group Co., Ltd. (SHA:600056)
10.93
+0.06 (0.55%)
Aug 18, 2025, 3:00 PM CST
China Meheco Group Revenue
China Meheco Group had revenue of 8.26B CNY in the quarter ending March 31, 2025, a decrease of -5.84%. This brings the company's revenue in the last twelve months to 33.64B, down -4.08% year-over-year. In the year 2024, China Meheco Group had annual revenue of 34.15B, down -12.04%.
Revenue (ttm)
33.64B
Revenue Growth
-4.08%
P/S Ratio
0.48
Revenue / Employee
4.02M
Employees
8,368
Market Cap
16.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 34.15B | -4.68B | -12.04% |
Dec 31, 2023 | 38.82B | 1.23B | 3.28% |
Dec 31, 2022 | 37.59B | 1.36B | 3.75% |
Dec 31, 2021 | 36.23B | -3.08B | -7.83% |
Dec 31, 2020 | 39.31B | 4.03B | 11.41% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
WuXi AppTec | 41.48B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |